Company Filing History:
Years Active: 2000-2002
Title: Maria Saveria Campo: Innovator in Papillomavirus Research
Introduction
Maria Saveria Campo is a distinguished inventor based in Glasgow, GB. She has made significant contributions to the field of cancer research, particularly in the study of papillomavirus. With a total of 3 patents to her name, her work has implications for both veterinary and human medicine.
Latest Patents
One of her latest patents is a method of treatment using papillomavirus L2 protein. This innovation involves cloning the L2 protein of papillomavirus, specifically BPV-2 and BPV-4, as a fusion protein with beta-galactosidase and GST. The research indicates that vaccination of calves can have both a prophylactic effect in tumor prevention and a therapeutic effect in tumor regression. Another notable patent focuses on L2 immunogenic peptides of papillomavirus. The N-terminal region of bovine papillomavirus (BPV-4) L2 protein includes three immunogenically active epitopes, two of which show substantial sequence homology to human papillomavirus (HPV) types. This research aims to produce vaccine formulations for use in both cattle and humans.
Career Highlights
Maria Saveria Campo is currently associated with Cancer Research Campaign Technology Limited, where she continues her groundbreaking work in cancer research. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in vaccine development.
Collaborations
She has collaborated with notable colleagues, including William Fleming Hogan Jarrett and William Fleming Jarrett, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Maria Saveria Campo's contributions to papillomavirus research exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a key figure in the ongoing fight against cancer.